Interestingly, the absence of IL-10 expression has been associated with poor outcome in stage I non-small cell lung cancer (NSCLC) [24], [25], while in late-stage NSCLC, the presence of IL-10-positive macrophages at the tumor margins can be an indicator of poor prognostic outcome [23]. This evidence concerns the gene IL10 and non-small cell lung carcinoma.